ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Data as of 2:25pm ET
 -0.16 / -0.61%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is developing a portfolio consisting of four advanced product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson's disease psychosis. It also has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma. ACADIA Pharmaceuticals was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Contact Information

ACADIA Pharmaceuticals, Inc.
11085 Torreyana Road
San Diego California 92121-1104
P:(858) 558-2871
Investor Relations:



Other institutional56.44%
Mutual fund holders39.28%
Individual stakeholders29.85%

Top Executives

Uli HacksellPresident, CEO, Director & CAO
Stephen R. DavisExecutive VP, Chief Financial & Business Officer
Roger M. MillsChief Medical Officer & Executive VP-Development
Terrence O. MooreChief Commercial Officer & Executive VP
Glenn F. BaitySecretary, Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.